Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for synthesizing aztreonam compound

A synthetic method and compound technology, applied in the field of medicine, can solve the problems of not being suitable for large-scale industrial production, not conducive to environmental protection, etc., and achieve the effects of saving production costs, reducing reaction time, and speeding up the reaction rate

Active Publication Date: 2011-07-20
SHANXI PUDE PHARMA CO LTD
View PDF5 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This method uses a highly toxic solvent, which is not conducive to environmental protection and is not suitable for large-scale industrial production.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing aztreonam compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Add 175g of purified water and 140g of methanol to the reaction vessel, add 20g of trans-3(S)-amino-4-methyl-2-oxo-1-azetidinanesulfonic acid, stir and cool down to -20°C . Keeping the temperature, start to add triethylamine dropwise until the pH value of the solution is 6.0. Begin to add (Z)-2-[(2-aminothiazol-4-yl)-(benzothiazol-2-ylthiocarbonyl)methyleneaminooxy]-2-methylpropionic acid tert-butyl ester 60g , During the feeding process, triethylamine is added dropwise, the pH value is always controlled between 5.0 and 9.0, the temperature is between -20 and -10, and the time is controlled within 2 hours. Continue to react for 2 hours. Filter, lower the temperature to -10°C, adjust the pH value to 1.5 with concentrated hydrochloric acid, white crystals are precipitated, keep warm and crystallize for 2 hours, filter to obtain tert-butylaztreonam.

[0031]Add tert-butylaztreonam into 3 times the amount of acetic acid and water mixed solvent (acetic acid: water = 5:5, ...

Embodiment 2

[0033] Add 200g of purified water, 100g of ethanol, and 100g of acetone into the reaction vessel, add 28g of trans-3(S)-amino-4-methyl-2-oxo-1-azetidinanesulfonic acid, stir and cool down to -30°C. Keeping the temperature, start to add triethylamine dropwise until the pH value of the solution is 8.0. Add (Z)-2-[(2-aminothiazol-4-yl)-(benzothiazol-2-ylthiocarbonyl)methyleneaminooxy]-2-methylpropionic acid tert-butyl ester 84g, During the feeding process, the pH value is always controlled between 5.0 and 9.0, and the temperature is between -20 and 0°C. The control is added within two hours. Continue to react for 2 hours, add activated carbon and stir for 0.5 hours. Filter, lower the temperature to -10°C, adjust the pH value to 1.0-1.5 with concentrated hydrochloric acid, white crystals precipitate, keep warm for 2 hours, and filter to obtain tert-butylaztreonam.

[0034] Add tert-butylaztreonam into a mixed solvent of 3 times the amount of acetic acid and water (acetic acid:...

Embodiment 3

[0036] Add 350kg of purified water, 280kg of acetone, and 40kg of trans-3(S)-amino-4-methyl-2-oxo-1-azetidinanesulfonic acid into the reaction vessel, stir and cool down to -20°C . Keeping the temperature, start to add triethylamine dropwise until the pH value of the solution is 5.0. Add (Z)-2-[(2-aminothiazol-4-yl)-(benzothiazol-2-ylthiocarbonyl)methyleneaminooxy]-2-methylpropionic acid tert-butyl ester 120kg, During the feeding process, the pH value is always controlled between 5.0 and 9.0, and the temperature is between -30 and -20°C. The control is added within 6 hours. Continue to react for 2 hours, add activated carbon and stir for 0.5 hours. Filter, lower the temperature to -20°C, adjust the pH value to 1.0-1.5 with concentrated hydrochloric acid, white crystals are precipitated, keep warm and crystallize for 2 hours, filter to obtain tert-butylaztreonam.

[0037] Add tert-butylaztreonam into 3 times the amount of acetic acid and water mixed solvent (acetic acid: wa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for synthesizing an aztreonam compound. The method comprises the following steps of: (1) adding water and a water-soluble non-aqueous solvent into a reaction container, adding trans-3(S)-amino-4-methyl-2-keto-1-azetidine sulfonic acid, triethylamine and (Z)-2-[(2-aminothiazole-4-radical)-(benzothiazole-2-sulfenyl carbonyl) methylamine oxygroup]-2-methylpropanoic acid tert-butyl ester for reacting, and adjusting the pH with acid and separating crystals out to obtain tertiary butyl aztreonam; and (2) subjecting the tertiary butyl aztreonam and acid-water mixed liquor to reaction and performing post-treatment to obtain aztreonam. By adopting the method, the reaction time can be shortened, the reaction speed can be increased, the production cost can be lowered, and environmental pollution can be reduced.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a method for synthesizing aztreonam compound. Background technique [0002] Aztreonam was the first monobactam antibiotic for clinical use. Developed by Bristol-Myers Squibb, it was first launched in Italy in 1984. The chemical name is: [2S-[2α, 3β(Z)]]-2-[[[1-(2-amino-4-thiazolyl)-2-[(2-methyl-4-oxo-1 -sulfo-3-azetidinyl)amino]-2-oxyethylene]amino]oxo]-2-methylpropanoic acid. Molecular formula: C 13 h 17 N 5 o 8 S. Molecular weight: 435.44. Structural formula: [0003] [0004] Aztreonam has a strong effect on Gram-negative bacteria and is stable to a variety of plasmid-mediated and chromosome-mediated β-lactamases. Some strains resistant to cephalosporin or penicillin antibiotics are still susceptible to aztreonam. Moreover, this product is safe and effective in clinical use, widely used in various infections, and the clinical effective rate is above ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D417/12
Inventor 解晓荣张磊李立忠李润宝王勇胡成伟
Owner SHANXI PUDE PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com